API Sourcing & Trade Finance — Sydney, Australia
Connecting Quality APIs with Global Markets
We supply WHO-GMP certified Active Pharmaceutical Ingredients to licensed manufacturers, backed by extended Usance letter of credit financing.
High-grade APIs
Extended trade credit
Zero factory downtime
- WHO-GMP & US-DMF Certified
- Deferred Usance L/C Terms
- Australian Corporate Governance
- Full Cold-Chain & CIF Logistics
Bridge between quality APIs and working capital
We solve the two biggest challenges in API procurement: supplier verification and foreign currency cash flow. We source directly from tier-1 synthesis plants and extend flexible credit terms so your factory stays running without draining cash reserves.
-
Preserve hard currency
Keep your working capital and USD reserves intact while securing high-demand active ingredients.
-
Eliminate port bottlenecks
Pre-structured banking facilities prevent shipping delays and customs holds at destination ports.
-
Match revenue cycles
Align raw material settlement dates with domestic distributor collection cycles.
Certified API sourcing, verified end to end
Direct access to audited tier-1 synthesis facilities, with complete CoA, US-DMF, CEP and WHO-GMP documentation on every shipment.
-
100% traceable
Complete CoA packages, US-DMF, CEP, and WHO-GMP compliance.
-
Full spectrum
High-volume solid orals, liquids, and sterile active ingredients.
-
Tier-1 partners
Direct access to audited global synthesis facilities.
Extended trade finance that protects your cash flow
Deferred Usance letter of credit structures through established Tier-1 Australian correspondent banking, built around your production and collection cycles.
-
Australian banking security
Trade credit facilities structured through established Tier-1 Australian correspondent networks.
-
Protect cash flow
Preserve working capital with custom deferred payment structures.
-
Usance L/C acceptance
Smooth letter of credit structures issued by leading commercial banks.
Regulatory and logistics assurance, built in
Rapid dossier access and strict USP/EP quality standards, with full CIF and CIP delivery direct to your destination port.
-
Instant dossiers
Rapid access to open DMFs for seamless local filings.
-
Guaranteed quality
Strict USP/EP standards to prevent factory QC rejections.
-
Flexible delivery
Full CIF and CIP terms directly to your destination port.
How it works - From Request to Delivery
A streamlined, secure and transparent process to source high-quality pharmaceutical APIs worldwide.
-
01
Request
Submit your required molecule, volume, and target port.
-
02
Quote
Receive a binding CIF price, CoA package, and credit terms.
-
03
Shipment
Your bank issues the Usance letter of credit; we dispatch factory-sealed drums.
-
04
Delivery
Goods arrive port-side with full regulatory dossiers, ready for production.
Letter of credit issuance guidelines
To ensure rapid processing, document verification, and immediate shipment release through our Australian trade desk, all Letters of Credit must adhere to the following baseline criteria.
- Format
- Irrevocable Usance Letter of Credit, issued via SWIFT (MT700).
- Governing rules
- Subject to the ICC Uniform Customs and Practice for Documentary Credits (UCP 600, latest revision).
- Tenor
- Deferred Usance terms — e.g. 60, 90, or 180 days from Bill of Lading date.
- Beneficiary
- Crest Pharma Group Pty Ltd (Sydney, Australia).
- Advising / discounting bank
- Details provided upon formal RFQ approval and contract execution.
- Required shipping documents
- Standard commercial invoice, full set Clean on Board Bills of Lading, Certificate of Analysis (CoA), Packing List, and WHO-GMP / Quality Dossier packages.
- Confirmation (if required)
- Confirmed by a top-tier international or multilateral bank.
Scale production without exhausting cash flow
Send us your molecule, volume, and destination port — our trade desk will return a binding CIF quote and financing terms.